Results 31 to 40 of about 801,766 (352)

Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study

open access: yesFrontiers in Oncology, 2022
In the last decade, targeting the immune system became a promising therapy in advanced lung cancer stages. However, in a clinical follow-up, patient responses to immune checkpoint inhibitors widely differ.
Marc A. Schneider   +18 more
doaj   +1 more source

Guanylyl cyclase activation reverses resistive breathing–induced lung injury and inflammation [PDF]

open access: yes, 2015
Inspiratory resistive breathing (RB), encountered in obstructive lung diseases, induces lung injury. The soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP) pathway is down-regulated in chronic and acute animal models of RB, such as ...
Brouckaert, Peter   +15 more
core   +2 more sources

The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases

open access: yesFrontiers in Microbiology, 2020
Emerging findings indicate there is a vital cross-talk between gut microbiota and the lungs, which is known as gut–lung axis. The gut disturbances in lung diseases including allergy, asthma, chronic obstructive pulmonary disease, cystic fibrosis and lung
Da-Peng Zhang   +5 more
semanticscholar   +1 more source

Systematic Review of Exposure to Polycyclic Aromatic Hydrocarbons and Obstructive Lung Disease [PDF]

open access: yesJournal of Health and Pollution, 2021
Background. There is fast-growing epidemiologic evidence of the effects of environmental chemicals on respiratory health. Polycyclic aromatic hydrocarbons (PAHs) have been linked with airway obstruction common in asthma and/or asthma exacerbation, and ...
Chinemerem C. Nwaozuzu   +2 more
doaj   +1 more source

Palliative care for people with non-malignant lung disease: summary of current evidence and future direction [PDF]

open access: yes, 2013
Background: The physical and psychosocial needs of patients with chronic non-malignant lung disease are comparable to those with lung cancer. This article will focus on chronic obstructive pulmonary disease, interstitial lung disease and cystic fibrosis ...
Boland, Jason   +5 more
core   +1 more source

Volumetric Imaging of Lung Tissue at Micrometer Resolution: Clinical Applications of Micro-CT for the Diagnosis of Pulmonary Diseases

open access: yesDiagnostics, 2021
Micro-computed tomography (micro-CT) is a promising novel medical imaging modality that allows for non-destructive volumetric imaging of surgical tissue specimens at high spatial resolution.
Andreana Bompoti   +12 more
doaj   +1 more source

Long-Term Efficacy of Pulmonary Rehabilitation in Patients with Occupational Respiratory Diseases [PDF]

open access: yes, 2012
Background: Pulmonary rehabilitation is a well-recognized treatment option in chronic obstructive lung disease improving exercise performance, respiratory symptoms and quality of life.
Jörres, Rudolf A.   +5 more
core   +1 more source

Getting it Right in Obstructive Lung Disease

open access: yesJournal of Clinical Medicine, 2023
Chronic hypercapnic respiratory failure in obstructive lung diseases may benefit from nocturnal Home non-invasive ventilation (HNIV). It has been shown that in patients with persistence of hypercapnia after an acute episode of chronic obstructive pulmonary disease (COPD) exacerbation requiring mechanical ventilation, HNIV may improve the risk for new ...
Carlucci, Annalisa, Fusar Poli, Barbara
openaire   +2 more sources

Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies.

open access: yesChronic obstructive pulmonary diseases, 2019
Background Metered dose inhalers (MDIs) are commonly prescribed for inhalation therapy, but correct use is critical to promoting effective medication delivery.
Soojin Cho-Reyes   +4 more
semanticscholar   +1 more source

Aerosol Delivery Devices for Obstructive Lung Diseases

open access: yesRespiratory care, 2018
Drug delivery by inhalation is the principal strategy to treat obstructive lung diseases, which affect about 15% of the population in the United States. Aerosol delivery devices have evolved over more than 60 years from the basic pressurized metered-dose
R. Pleasants, D. Hess
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy